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The emergence of cells from a quiescent Go arrested state into the cell cycle is a multistep
process that begins with the immediate early response to mitogens and extends into a
specialized G1 phase. Many immediate early serum response genes including c-fos, c-myc,
and c-jun are transcriptional regulators. To understand their roles in regulating cell cycle
entry and progression, the identities of their regulatory targets must be determined. In this
work we have cloned cDNA copies of messenger RNAs that are either up- or down-
regulated at a mid-G1 point in the serum response (midserum-response [mid-SR]). The
mid-SR panel is expected to include both direct and indirect targets of immediate early
regulators. This expectation was confirmed by the identification of several transcriptional
targets of conditional c-myc activity. In terms of cellular function, the mid-SR class is also
expected to include execution genes needed for progression through G1 and into S-phase.
DNA sequence data showed that the mid-SR panel included several genes already known
to be involved in cell cycle progression or growth transformation, suggesting that previously
unknown cDNAs in the same group are good candidates for other G1 execution functions.
In functional assays of Go -* S-phase progression, c-myc expression can bypass the re-
quirement for serum mitogens and drive a large fraction of Go arrested cells through G1
into S-phase. However, beyond this general similarity, little is known about the relation
of a serum-driven progression to a myc-driven progression. Using the mid-SR collection
as molecular reporters, we found that the myc driven G1 differs qualitatively from the
serum driven case. Instead of simply activating a subset of serum response genes, as might
be expected, myc regulated some genes inversely relative to serum stimulation. This suggests
that a myc driven progression from Go may have novel properties with implications for
its action in oncogenesis.
INTRODUCTION
When exponentially growing NIH or Balb/c 3T3 cells
are deprived of serum growth factors, cell cycle pro-
gression halts after mitosis and the cells enter a prolif-
eration arrested state termed Go. Restoration of mitogens
activates signaling cascades that stimulate emergence
from Go growth arrest and support further cell cycle
progression (for review, see Pardee, 1989). The G1 phase
that follows is specialized and temporally protracted
t To whom correspondence should be addressed.
compared with the G1 of cycling cells. The Go>o-S-phase
progression is of interest because for many vertebrate
cell types it is the major decision point regulating cell
proliferation and execution of cell differentiation pro-
grams.
At the molecular level, a good deal is now known
about the earliest events at the GO/Gl transition, but
less is known about subsequent events in the specialized
G1 that follows. The initial response of Go arrested cells
to serum growth cues is characterized by rapid, robust,
protein-synthesis-independent up-regulation of tran-
scription from a specific set of genes (Lau and Nathans,
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1987; Almendral et al., 1988; Mohn et al., 1991). Prom-
inent among these immediate early response genes are
known or suspected transcription factors of the AP-1,
myc, nuclear receptor, and zinc finger families (for re-
view, see Bravo, 1990). Their dramatic synthesis at the
Go/Gl transition suggests that they are members of a
regulatory heirarchy that initiates progression through
Gl. From a cell biological perspective, it is now impor-
tant to identify genes that are up- or down-regulated
during mid-G1 of the serum response (midserum-re-
sponse [mid-SR]) and define their individual and col-
lective roles in execution of cell proliferation. From a
molecular perspective, these mid-SR genes are likely to
include physiological targets of the immediate early
transcription regulators and as such serve as natural
reporters for their function. A primary goal of this work
was to expand the repertoire of cloned mid-SR genes.
Ectopic expression of c-myc in Go arrested cells can
drive them through GC and into S-phase (Cavalieri and
Goldfarb, 1987; Eilers et al., 1991). Myc is a component
of a sequence specdfic DNA binding transcription factor.
In vitro studies have shown that c-myc homodimerizes
poorly and as a result binds its preferred site, CACGTG,
inefficiently (Blackwell et al., 1990). But in collaboration
with its pairing partner, Max/myn (Blackwood and Ei-
senman, 1990; Prendergast et al., 1991) it forms het-
eromers that bind DNA very efficiently. This protein:
protein association is likely to be physiologically relevant
because it is also observed in vivo (Wenzel et al., 1991;
Blackwood et al., 1992). In serum stimulated NIH or
Balb/c 3T3 cells, the temporal pattern of immediate
early c-myc expression and delayed early Max/myn
expression (Prendergast et al., 1991) suggests that the
activity of a putative c-myc:Max/myn heteromeric
transcription factor will be stimulated by serum and
will peak during the extended G1 that follows. This leads
to the hypothesis that myc, in association with Max/
myn or some similar partner, is responsible for regu-
lating an identifiable subset of the mid-SR genes. Fur-
thermore, the myc responsive gene class is sufficient to
drive progression from Go to S. Therefore, a second
goal in this work was to identify mid-SR genes that are
subject to myc regulation.
In this work, we prepared cDNA libraries from
growth arrested and mid-GC serum stimulated 3T3 cells,
differentially screened those libraries with correspond-
ing cDNA probes, and obtained a panel of cDNA clones
subject to either up- or down-regulation with mid-SR
kinetics. These mid-SR genes were subsequently
screened to identify a subset that are regulated in re-
sponse to conditional c-myc expression. Several were
identified and shown to be transcriptionally regulated
in response to myc. The mid-SR panel was also used to
evaluate the similarity of a myc-driven GC to a serum
driven Gl. Several genes responded similarly to serum
and conditional c-myc activity and are therefore can-
didates for common execution functions for progression.
Others, however, responded inversely to the two stim-
uli, suggesting that the G1 progression elicited by myc
differs qualitatively from the serum response.
MATERIALS AND METHODS
Recombinant Plasmids Used in Stable Transfections
Plasmid myc23c encodes the mouse c-myc proto-oncogene and was
used to stably transfect NIH 3T3 cells. The plasmid was assembled
in several steps in pT7T3-18 (Bethesda Research Laboratories, Gaith-
ersburg, MD). From 5' to 3', it consists of a 756 bp Taq I-Sac I fragment
from the MTV LTR bearing a glucocorticoid regulated enhancer (Pay-
var et al., 1983), a 218 bp Sac I-Bgl II fragment containing the mouse
metallothionein I (Mt-I) promoter (Mueller et al., 1988), a 550 bp Xba
I-Sac II fragment from the first intron and second exon of the mouse
c-myc genomic clone lambda myc 5 (Hood and Barth, unpublished
observations), a 922 bp Sac II-Nsi I fragment containing the remainder
of the c-myc coding sequence derived from the c-myc cDNA myc 29
(Mueller, Kim, and Wold, unpublished observations), and a 302 bp
Hgi AI-HindIII fragment containing the poly-A addition signal from
the mouse Mt-I gene (Mueller et al., 1988). The Taq I site at the 5' end
of the enhancer fragment was filled-in with Klenow polymerase and
ligated to a filled-in EcoRI site within the polylinker, regenerating the
EcoRI site. The Bgl II site at the 3' end of the Mt-I promoter was ligated
into the BamHI site of the polylinker, destroying both sites; similarly,
the Nsi I-Hgi Al fusion between the 3' end of the myc cDNA fragment
and the 5' end of the Mt-I poly-A addition fragment destroyed both
sites. Plasmid pNeo 3, an HSV-tk promoted neo construct (Bond and
Wold, 1987), was used as a G418 selectable marker in the preparation
of stably transfected cell lines.
Stable Transfections
At the outset of this work, NIH 3T3 cells and c-myc transfected de-
rivatives were maintained in Dulbecco's modified Eagle medium
(DMEM) supplemented with 10% fetal bovine serum (Hydone, Logan,
UT), 100 U of penicillin G per milliliter, and 7.5 U of streptomycin
per milliliter. Cells were transfected with a calcium phosphate co-
precipitate of plasmid and carrier DNAs by a standard procedure
(Wigler et al., 1979). Using pNeo 3 as a selectable marker, NIH 3T3
cells co-transfected with pmyc23c were selected for growth in G418
(Gibco, Grand Island, NY). In the first two sets of transfections, rel-
atively fast growing clones were chosen for individual analysis, while
remaining clones were pooled. Of more than fifteen individual clones
checked, none synthesized more RNA from the myc23c transgene
than from their endogenous c-myc gene. In contrast, the pooled cell
lines expressed considerably more myc23c RNA. In a third transfection,
slow growing clones were deliberately selected. Of 10 clones tested,
4 expressed high levels of the myc23c mRNA. Initial analysis of RNA
from these cells using probes sensitive to the 5' and 3' ends of the
myc23c transcript showed that the predicted transcript was made.
Subsequently, several individual myc23c expressing lines were reiso-
lated from the myc23c expressing pools.
Cell Culture
Routine culture of NIH 3T3, c-myc transfected derivatives thereof,
and Balb/c 3T3 cells was in DMEM with 15 mM N-2-hydroxyeth-
ylpiperazine-N'-2-ethamesulfonic acid (HEPES) (Irvine Scientific,
Santa Ana, CA) supplemented with 10% calf serum (Gibco) and 1X
glutamine/pen/strep (Irvine Scientific). For experiments comparing
Balb/c 3T3 cells with those expressing a c-myc/estrogen receptor
fusion protein (MER #6 cells) (Eilers et al., 1989, 1991), both lines
were maintained in phenol red free DMEM supplemented with 5%
calf serum (Gibco), 4 mM HEPES free acid, and 1X glutamine/pen/
strep.
Two growth arrest protocols used were the following: 1) low-density
arrest in defined medium and 2) arrest by contact inhibition in medium
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containing 5% calf serum. Culture in defined medium was essentially
as in Zhan and Goldfarb (1986), with the modifications noted below.
Tissue culture dishes (15 cm and 24 well, Nunc) were first coated
with polylysine (1 mg/ml in H20, Sigma) for 2-3 hours at 370, rinsed
with phosphate buffered saline (PBSA), and coated overnight at room
temperature with bovine fibronectin (15 Mg/ml in PBSA, Sigma). For
cell cycle progression work and RNA preparation, defined medium
(DMI-2) consisted of DMEM F-12 HEPES (Flow Laboratories, McLean,
VA), 4 AM manganese chloride, 10 AM ethanolamine, 100 nM sodium
selenite, 1X glutamine (Irvine Scientific), 5 Mg/ml apotransferrin
(Sigma), and 500 MAg/ml bovine serum albumin-linoleic acid complex
(Sigma). Hormonal supplements were 30 ng/ml insulin and 10 pg/
ml TGF-f (RD Systems, Minneapolis, MN). We found that low con-
centrations of TGF-,B, which should facilitate assembly of exogenous
fibronectin (Allen-Hoffman et al., 1988), improved cell survival
through the timecourse of the experiments. We did not add histidine
or hydrocortisone.
For defined medium based experiments comparing Balb/c 3T3 cells
with MER #6 cells, defined medium (DMI-3) consisted of 1:1 phenol
red free DMEM and phenol red free F12 (Gibco), 10 mM HEPES pH
7.2,4 MM manganese chloride, 10 MM ethanolamine, 100 nM sodium
selenite, 1X glutamine/0.1X pen/strep (Irvine Scientific), 5 Mg/ml
apotransferrin, 500 Mg/ml bovine serum albumin-linoleic acid com-
plex, 30 ng/ml insulin, and 10 pg/ml TGF-#.
For density arrest-based experiments comparing Balb/c 3T3 cells
with MER #6 cells, cells were brought to growth arrest on fibronectin
coated plates in phenol red free DMEM that had been adjusted to 4
mM HEPES with the addition of dry HEPES free acid, 5% calf serum,
1X glutamine/pen/strep, and 1X GMS-X medium supplement
(Gibco).
RNA Preparation
Polylysine/fibronectin coated 15-cm plates were seeded at a density
of 3 X 106 cells per plate in 25 ml of DMEM plus 10% calf serum.
Twelve hours later the cells were washed with PBS and fed with 25
ml of DMI (defined medium). Twelve hours later the cells were refed
with 25 ml of DMI. Twenty-four hours later the cells were serum
induced with the addition of FBS to 10% final concentration, zinc
induced with the addition of various concentrations of zinc sulfate
(diluted in DMEM phosphate free HEPES [Irvine]), or mock induced
with the addition of an appropriate volume of DMEM phosphate free
HEPES.
When RNA was intended for library or probe preparation, cells
were harvested in 5 M guanidinium thiocyanate, 50 mM
tris(hydroxymethyl)aminomethane (Tris) pH 7.5, 12.5 mM EDTA, 2%
N-lauryl sarcosine, and 1% 2-mercaptoethanol. Lysates were adjusted
to 1.5 Mg/ml ethidium bromide and an approximate density of 1.6
g/ml with CsTFA (Pharmacia, Piscataway, NJ). Lysates were spun at
41,500 rpm for 30 h in an SW55 rotor, the RNA band was withdrawn,
ethanol precipitated twice, and redissolved in 10 mM Tris, 1 mM
EDTA, pH = 7.8 (TE) (Mirkes, 1985). RNA intended for ribonuclease
(RNase) protections was prepared by a modified guanidinium thio-
cyanate/organic extraction protocol (Chomczynski and Sacchi, 1987).
cDNA Clone Selection and Management
1) Poly A plus RNAs were prepared from growth arrested and 8 h
serum-stimulated Balb/c 3T3 cells. 2) First strand cDNAs were even-
tually used as probes. Hemimethylated double stranded cDNAs were
directionally cloned into the vector X EXLX+ (Palazzolo et al., 1990).
3) Biotinylated cRNA was prepared by transcribing phage library
DNAs en masse with T7 RNA polymerase and a nucleotide mixture
containing biotinylated UTP (BRL). Biotinylated cRNA from the growth
arrested library was hybridized to serum stimulated cDNA and bio-
tinylated cRNA from the serum stimulated library was hybridized to
growth arrested cDNA. Heteroduplexes and unhybridized cRNA were
removed with the addition of streptavidin followed by phenol ex-
traction. 4) The resultant subtracted cDNAs were 32P labeled by prim-
ing with random nonamers and extending with T7 DNA polymerase.
A "backprobe" was generated by similarly labeling a limited collection
of serum regulated clones plus clones selected in preceeding rounds
of library screening (see step 6). 5) X libraries were plated at a density
of 1000 plaques per 15-cm plate. Three lifts were made from each
plate. One lift was probed with the growth arrested subtracted probe,
a second lift was probed with the serum stimulated subtracted probe,
and a third lift was probed with the backprobe. Plaques differentially
hybridized to by the first and second probes and not labeled by the
backprobe were picked for further analysis. 6) cDNA inserts were
PCR amplified from primary plaques using primers based on flanking
vector sequences. The 3' end primer was 32P labeled, resulting in 3'
end labeled cDNAs. After gel purification, fragments were subjected
to partial restriction digest mapping from their 3' ends with Hae III,
Hin fI, and Sau 3A. Restriction maps were compared by computer
analysis (Tavtigian 1992). Where a mRNA species was represented
by more than one clone, only the longest corresponding cDNA was
used for further analysis. cDNAs from this level of analysis were
combined for use in the backprobe [see step 4]. The mid-Gi library
was screened through six rounds of six plates each, while the growth
arrested library was screened for two rounds of six plates.
An important practical issue was to reduce labor by eliminating
redundant clones as early in the process as possible. At the level of
initial plaque screens, we reduced the repeated selection of cDNAs
derived from a few prevalent and differentially expressed mRNAs.
As indicated in Figure 1, this was done by proceeding through several
successive rounds of library screening, making triplicate lifts from
each plate. The differential probes were hybridized to the first and
second lifts, whereas a backprobe, generated by pooling cDNAs al-
ready obtained in earlier rounds of screening, was hybridized to the
third lift; only plaques yielding differential signals on the first and
second lifts and scoring negative on the third lift were selected. To
further reduce the number of redundant clones maintained after a
given round of screening, restriction maps were generated from the
3' ends of the newly selected clones and a computerized comparison
of the new clone restriction maps with the existing clone maps was
used to identify and omit redundant clones. Plasmids bearing poten-
tially unique cDNAs were automatically subcloned (Palazzolo et al.,
1990). The resulting plasmid miniprep DNAs were sequenced from
their 5' ends, yielding 250 to 325 bp of sequence from each clone.
Sequences were searched against the Genbank and EMBL sequence
libraries using the program BLAST (Altschul et al., 1990). Remaining
redundant cDNAs identified during the database searches, usually
either short or internally initiated copies of highly expressed mRNAs,
were eliminated at this stage.
Characterization
1) cDNA bearing plasmids were excised from primary X clones by
a cre-lox recombination system (Palazzolo et al., 1990). Where more
than one cDNA was obtained from the primary plaque, they were all
maintained for further analysis. 2) cDNAs were Sanger-sequenced
from their 5' ends. 3) Resultant sequences were used to generate re-
striction maps as well as to search for sequence homologies in GEN-
BANK and EMBL using the program BLAST (Altschul et al., 1990).
4) A 5' end fragment from each cDNA was subcloned into a dual
polymerase promoter plasmid to generate a riboprobe template. 5)
The expression timecourse of each RNA in serum stimulated NIH
3T3 cells was checked by ribonuclease protection (Zinn et al., 1983).
6) Expression of those RNAs subject to serum regulation with mid-
SR kinetics was further characterized in the conditional myc-expressing
cell lines 3-5B and MER #6.
PCR cloning
Probes for the transcripts prothymosin a and Max/myn were cloned
by amplification from first strand cDNA. PCR primers were the fol-
lowing
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prothymosin a 5': CGC GAA TTC ATG TCA GAC GCG GC[A/
C/G/T] GT[A/C/G/T] GA
prothymosin a 3': CGC GGA TCC CTG CTT CTT GGT [C/T]TC
[A/C/G/T]AC [G/AJTC
Max/myn 5': GCA GAT CTG CCA CCA TGA GCG ATA ACG
ATG ACA T[C/T]G A[G/A]G T
Max/myn 3': GCG TCG ACT CAG CTG GCC TCC ATC CGG
A[G/A][C/T] TT[C/TJ TT
The Prothymosin a PCR product was cloned as an Eco RI-Bam HI
fragment into a dual promoter vector to serve as a riboprobe template.
A Bgl II (PCR generated site)-Sma I fragment from the 5' end of Max/
myn was subcloned for the same purpose.
Other Riboprobe Templates
Several other plasmids were prepared for use as riboprobe templates
in the work. pmycl-HA contains a 122 bp HindIII-Alu I fragment
from the first exon of c-myc. The HindIII site is located between P1
and P2 (Bernard et al., 1983) within the c-myc promoter. pmyc2-XR
contains a 192 bp Xba I-Eco RV fragment starting near the 3' end of
the first intron of c-myc and extending into the second exon. pMHS-
SX contains a 646 bp Sma I-Xba I internal fragment from the mouse
HSP 70 cDNA MHS 214 (Lowe and Moran, 1986). pfos-PP2 contains
a 108 bp Pvu H-Pst I fragment spanning the 5' end of the c-fos transcript
(Van Beveren et al., 1983). pp53-XA contains a 1005 bp Xho I-Asp
718 fragment from the p53 tumor antigen gene (Tan et al., 1986). p#5
contains an approximately 135 bp 3' end fragment from a mouse
tubulin,B5 cDNA (Lewis et al., 1985) from which the poly-A tract has
been trimmed with exonuclease Bal 31.
RNA Measurement
RNA probes were synthesized using T7, T3, or SP6 RNA polymerase
essentially as recommended by the enzyme manufacturers. Full length
probes were excised from 5% acrylamide gels crosslinked with BAC
(N,N'-bis-acrylylcystamine, Bio-Rad, Richmond, CA) and the acryl-
amide was dissolved with 200 mM 2-mercaptoethanol in TE. RNase
protections were performed by a modification of the procedure de-
scribed by Zinn et al. (Zinn et al., 1983). One or two micrograms of
cellular RNA plus sufficient tRNA carrier to make an RNA total of
25 Mg were coprecipitated with probe. Samples were redissolved in
30 ,ul of RNA hybridization buffer (40 mM piperazine-N,N'-bis(2-
ethanesulfonic acid [PIPES] pH 6.7,400mM NaCl, 1 mM EDTA, 80%
formamide), denatured at 800 for 10 min, and hybridized for >12 h.
Probe concentrations and hybridization temperatures were optimized
so that hybridizations proceeded to at least 90% of completion in 12
h. Hybridizations were digested with the addition of 300 Ml of 1500
units/ml RNase Ti (BRL) in RNase digestion buffer (10 mM Tris pH
7.5, 300 mM NaCl, 5 mM EDTA) for 60 min at 300, followed by 200
MAI of 250 Mug/ml proteinase K, 1% sodium dodecyl sulfate (SDS) for
15 min at 300. Handling of samples containing dissolved BAC acryl-
amide was facilitated by co-precipitating RNA samples and probe out
of 100 mM 2-mercaptoethanol and using silanized tubes. Samples
were prepared for electrophoresis and fractionated on 5% denaturing
acrylamide gels, which were then dried and exposed to X-ray film.
Count per minute data were obtained from the dried gels on a phos-
phoimager (Molecular Dynamics, Sunnyvale, CA) and converted to
transcript per cell data using internal CPM standards.
DNA Replication Assays
For experiments with NIH 3T3 and 3-5B cells, Polylysine/fibronectin
coated 24 well plates were seeded at a density of 2 X 104 cells per
well in 0.5 ml of DMEM plus 10% serum. Twelve hours later the cells
were washed with PBS and fed with 0.75 ml of DMI. Twelve hours
later the cells were refed with 0.75 ml of DMI. Twenty four hours
later the cells were zinc induced with the addition of various concen-
trations of zinc sulfate in DMEM phosphate free HEPES, mock induced
with the addition of an appropriate volume of DMEM phosphate free
HEPES, or serum induced with the addition of FBS to 5% final con-
centration. For experiments with Balb/c 3T3 and MER #6 cells, fi-
bronectin-coated 24 well plates (Collaborative Research, Bedford, MA)
were seeded at a density of 3 X 10' cells per well in 0.5 ml of phenol
red free DMEM that had been adjusted to 4 mM HEPES with the
addition of dry HEPES free acid, 5% calf serum, 1X glutamine/pen/
strep, and lx GMS-X medium supplement. Twenty-four hours later
the cells were refed with 0.75 ml of the same medium. Seventy-two
hours later the cells were (1-estradiol induced with the addition of
various concentrations of,B-estradiol in phenol red free DMEM, mock
induced with the addition of an appropriate volume of phenol red
free DMEM, or serum induced with the addition of FBS to 15% final
concentration. In both procedures, entry into S-phase was monitored
by adding 37.5 Ml of a labeling mixture containing 5-bromodeoxy-
uridine and 5-fluorouracil (Amersham, Arlington Heights, IL) 14 h
after stimulation. Experiments were terminated 10 h after labeling
mix addition by washing the cells with PBSA and then fixing them
in 5% acetic acid in ethanol. Immunoperoxidase staining employed
the Amersham cell proliferation kit. Wells were washed three times
for 3 min with PBS, incubated with eightfold diluted anti-BrdU mAB/
nuclease mix for 4 h at room temperature, washed three times for 3
min with PBS, incubated with fourfold diluted peroxidase labeled
anti-mouse Ab for 2 h at room temperature, washed three times for
3 min with PBS, stained with nickel/cobalt enhanced DAB, and
counterstained with fast green FCF.
Western Blots
Polylysine/fibronectin coated 6-cm plates were seeded at a density
of 2.5-4.0 X 105 cells per plate in DMEM plus 10% calf serum. Twelve
hours later cells were washed with PBSA and fed with 3 ml of DMI.
Twelve hours later cells were refed with 3 ml of DMI. Twenty-four
hours later cells were induced with 300 Ml of 3:1 DMEM:F12, 150 Ml
of fetal bovine serum (Hazleton Biologics, Lenexa, KS), or 300 Al of
220 MM ZnSO4 in 3:1 DMEM:F12. Cells were harvested over a 16-h
timecourse as indicated in the Figure 4 legend. Cells were lysed in
200 MI of loading buffer (80 mM Tris pH 6.8, 100 mM dithiothreitol,
2% SDS, 10% glycerol). Cell lysates were fractionated on acrylamide
SDS gels and electroblotted to Nitroplus 2000 (Micron Separations,
Westboro, MA). Filters were blocked for 2 h at room temperature in
1X Tris-buffered saline (TBS), 0.5% Tween 20, 2% BSA. Antibody
incubations were in the same solution with the addition of 2 Mg/ml
anti-myc monoclonal antibody H60C37 '25I-labeled to a specific ac-
tivity of 100 Ci/mM. Antibody incubations were for 12 h, followed
by five 20-min washes in blocking solution.
Nuclear Run-on Assays
For nuclear run-ons, MER #6 cells were brought to growth arrest by
contact inhibition in phenol red free DMEM that had been adjusted
to 4 mM HEPES with the addition of dry HEPES free acid, 5% calf
serum, 1X glutamine/pen/strep, lx GMS-X medium supplement
(Gibco), and 100 Mg/ml G418 (Gibco). Preparation of nuclei and tran-
scription reaction conditions were modified from Greenberg and
Bender (1990). Cells from six 15-cm plates (-2 X 10' cells/plate)
were washed twice with PBS, scraped with a rubber policeman, and
centrifuged for 5 min at 500 X g at 4°. All subsequent steps were
carried out at 4°. Supernates were removed and cells resuspended in
40 volumes of lysis buffer (10 mM Tris pH 7.4, 3 mM CaCl2, and 2
mM MgCl2). Cells were centrifuged for 5 min at 500 X g, supernates
were removed, and cells were resuspended in 2 ml of lysis buffer
followed by the addition of 2 ml of lysis buffer plus 1% NP-40. The
preparations were transferred to a dounce and remaining intact cells
broken by 12 strokes of the homogenizer. The lysates were spun at
500 g for 5 min, supernates were removed, and nuclei resuspended
in 400 Ml of glycerol buffer (50 mM Tris pH 8.3, 40% glycerol, 5 mM
MgCl2, and 0.1 mM EDTA).
Fresh nuclear preparations were mixed with 400 ,ul of 2X reaction
buffer (10 mM Tris pH 8.0, 5 mM MgCl2, 300 mM KCl, 5 mM DTT,
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and 1 mM each ATP, CTP, and GTP) containing 300 ACi of a-32P
UTP at 800 Ci/mM and 40 units of RNasin. Reactions were incubated
for 20 min at 300. One and one-fifth microliters of HSB (10 mM Tris
pH 7.4, 500 mM NaCl, 50 mM MgCl2, and 2 mM CaCl2) was then
added to each reaction, and DNA in the reaction mixtures was digested
with 100 units of DNase I (RQ1, Promega, Madison, WI) for 15 min
at 300. Four hundred milliliters SDS/Tris buffer (500 mM Tris pH
7.4, 5% SDS, and 125 mM EDTA) was added; and the reactions were
digested with 400 ,ug of proteinase K for 30 min at 42°. The RNA
preparations were then extracted with phenol chloroform and iso-
propanol precipitated. Pellets were redissolved in 1 ml of DNase buffer
(20 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM CaCl2), incubated
for 10 min at 37°, and redigested with 50 units of RQ1 DNase for 30
min at 37°. The DNase reactions were stopped with the addition of
EDTA to 15 mM and SDS to 0.9%, digested with 60 Mg of proteinase
K for 30 min at 37°, and phenol chloroform extracted. The RNA
preparations were denatured with 250 Ml of 1 M NaOH for 10 min
on ice, neutralized with 500 ,l of 1 M HEPES (free acid), and isopro-
panol precipitated.
The RNA pellets were redissolved in 1 ml of TES solution (10 mM
TES [N-tris(hydroxymethyl)methyl-2-aminoethansulfonic acid]
(Sigma) pH 7.4, 10 mM EDTA, and 0.2% SDS) for 30 min at RT,
mixed with 1 ml of TES/NaCl (TES solution plus 600 mM NaCl),
and hybridized for 60 h at 650 to linearized, denatured plasmid DNAs
that had been dot-blotted and UV crosslinked onto Hybond-N strips
(Amersham). Plasmids used were pI-8-lOB (LDH), pI-8-29, and pl-
8-36 (ODC) (obtained from differential screening of the mid-Gl serum
stimulated cDNA library), and pmyc A, a full length c-myc cDNA
that was obtained during initial characterization of the mid-Gl serum
stimulated cDNA library. Filters were washed twice in 2X SSC for
60 min at 650, digested with RNase A at 100 ,g/ml in 2X SSC for
30 min at 370 and washed for an additional hour in 2X SSC at 370.
The filter strips were then air dried and exposed on a phosphoimager
(Molecular Dynamics).
RESULTS
Cloning Strategy
The initial goal in this work was to identify mid-SR
class genes. cDNA libraries were prepared from both
serum starved and 8-h serum stimulated Balb/c 3T3
cells. These libraries were screened with probes enriched
for sequences either induced or repressed in response
to mitogen stimulation. Figure 1 presents an outline of
the cloning strategy (see MATERIALS AND METHODS
for a detailed description). The design was influenced
by several considerations. First, we focused the selection
scheme on the kinetics of progression through G, fol-
lowing emergence from Go. In this experimental regime,
the 8-h timepoint is reproducibly within G1, close to
the restriction point (R-point), beyond which entry into
S-phase becomes insensitive to inhibition by serum re-
moval (Pardee, 1989). Thus, execution genes whose new
transcription and translation are needed for progression
from G1 to S should be well-represented at the 8-h point
(entry into S under these conditions is at 14 h). The
8-h point was also expected to allow for the decay of
prominent Go transcripts derived from genes that are
down-regulated in response to serum. We will refer to
transcripts differentially regulated at 8 h as mid-serum
response, or mid-SR, to distinguish them from a poten-
tially distinct class regulated in mid-GC of exponentially
growing cells. A second strategic consideration was that
A. cDNA library preparation
1. prepare ds cDNA from 8 hour serum stimulated cells; clone into X ExLx
U15X106 independent clones
2. prepare ds cDNA from Go arrested cells; clone into X ExLx
* 7x106 independent clones
B. Probe preparation (for the serum stimulated case only; the growth arrested
probe was prepared via the reciprocal hybridizations)
1. 10 (unsubtracted) probe: ss cDNA derived from serum stimulated cells
2. preparation of subIracting cRNA
a. prepare X DNA from arested library
b. transcribe with T7 RNA pol and biotinylated NTPs
-o. biotinylated sense cRNA
3. preparation of subtracted cDNA
a. hybridize 1° ss cDNA with biotinylated cRNA
b. remove heteroduplexes and cRNA
*. serum stimulated subtracted cDNA probe - the unreacted
ss cDNA is enriched for sequences differentially up-regulated
in seum stimulated cells
C. Library screening
1 plate at low density: -1000 plaques per plate
2. make 3 lifts per plate:
a. screen with the serum stimulated subtracted probe
b. screen with the arrested subtracted probe
c. screen with the 'backprobe' (see below)
3. seled dones that:
a. score positive with the serum stimulated probe
b. score negative wih the arrested probe
c. score negative with the backprobe
low redundancy serum stimulated cDNA clones
D. Preparation of backprobe
1. PCR amplify cDNA inserts from selected clones
2. gel purify and pool DNAs
o- backprobe
Figure 1. Flow chart of the cDNA library screening strategy.
we wanted to obtain clones corresponding to mRNAs
of all prevalence classes. This was achieved by using
subtracted hybridization probes enriched in differen-
tially expressed sequences, which effectively increased
the screening sensitivity for lower abundance cDNAs
(Sargent, 1987; Palazzolo et al., 1990). Third, we antic-
ipated that some genes whose expression is initiated
early, qualifying them as members of the immediate
early kinetic class, will continue to be expressed through
G1, and that this later phase of expression may also
identify them as mid-SR class genes. c-Myc itself, for
example, displays such a pattern of expression (Muller
et al., 1984; Lau and Nathans, 1987). While there are
several different possibilities for the regulatory basis of
such expression, we wanted to detect such genes in the
initial screen. For this reason, we did not initially elim-
inate all immediate early class genes but later identified
them as a kinetic subset.
The growth arrested and serum stimulated cDNA li-
braries contained 7 X 106 and 1.5 X 107 clones, respec-
tively. Because the fibroblasts used in this work contain
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in the range of 3-10 X 105 mRNA molecules per cell
(endrisak et al., 1987), the libraries are large enough to
ensure that even the rarest mRNA species are repre-
sented, except for possible exceptional sequences that
may have been peculiarly poor substrates for reverse
transcription. Although the libraries are comprehensive,
the screening reported here was not extensive enough
to be saturating and was more complete for the serum
induced case than for the repressed case. The serum
stimulated library was screened through six rounds of
six plates each (at -1000 plaques per plate), and the
growth arrested library was screened through two
rounds of six plates each (see MATERIALS AND
METHODS for details of screening and clone manage-
ment). From 100 differentially hybridized plaques ~-40
cDNAs were found to be nonredundant by the criteria
of 3' end restriction mapping and limited 5' end sequence
analysis. These were subjected to further analysis.
Expression in Growth Arrested and Serum
Stimulated Cells
The 40 candidate 8-h response clones were tested for
the kinetics of their response to serum. Members of the
immediate early kinetic class were identified and sep-
arated from those clones whose RNAs were most
strongly differentially regulated at the 8-h mid-G1 point.
For operational purposes, we defined mid-SR regulated
clones as those either 1) expressed at higher levels 8 h
following serum stimulation than 1 h following or 2)
repressed during GI following serum stimulation of
quiescent cells. To confirm magnitude and timing of
regulation, ribonuclease protection assays were used.
RNAs used for screening were from NIH 3T3 cells that
had been brought to growth arrest in defined medium,
then mock or serum induced for 1 or 8 h. In addition,
each clone was tested for expression in asynchronous
exponentially growing cells. RNA from NIH 3T3 cells
was used in rescreening to filter out any clone whose
response was particular to the Balb/c 3T3 line used to
construct and screen the original libraries. Of the 40
unique clones obtained from initial screens, 18 were
classified as mid-SR genes; 15 of these were induced
(Figure 2B) and 3 were repressed (Figure 2C) by serum
treatment. The remaining clones were either subject to
stimulation by serum with predominantly early G, ki-
netics or were not reproducibly regulated. Clones ex-
pressed most highly at 1 h have not yet been sub-
screened to differentiate those that are regulated
independently of protein synthesis (the criterion that
distinguishes the immediate early class) from those that
are dependent on immediate early products. Nomen-
clature: serum stimulated clones were initially named
I-8-x where I-8 indicates serum induced at 8 h and x is
the number assigned to the primary plaque upon its
selection. Repressed clones were named R-8-x where
R-8 indicates serum repressed at 8 h. Where an original
phage plug later proved to contain more than one cDNA
clone, the clone number is followed by a letter, i.e., I-
8-10A and I-8-1OB. DNA sequencing was performed to
determine possible identities of the cDNAs. Several
proved to be known genes or their near relatives, while
others were not detectably homologous to sequences in
GENBANK. Because our screening was not saturating,
we expect that there are many other mid-SR cDNA spe-
cies that remain to be identified. A conceptually similar
search for genes expressed in this pattern was recently
reported (Lanahan et al., 1992), and it identified 13 de-
layed early response genes that are not overlapping with
those reported here.
For comparison of mid-SR genes with other work,
panel A of Figure 2 presents the classic immediate early
transcripts c-fos and c-jun (Muller et al., 1984; Lau and
Nathans, 1987; Almendral et al., 1988), as well as the
additional recently cloned genes of potential interest,
Max/myn and Id (Benezra et al., 1990; Blackwood and
Eisenman, 1990; Prendergast et al., 1991). The serum
induced 1-8 clones (panel B) and serum repressed R-8
clones (panel C) correspond to mRNAs from all prev-
alence classes, as anticipated from the cloning strategy.
For example, 1-8-16 (cytoplasmic [A-X] actin), R-8-1 (al-
pha-1 [3] collagen), and R-8-9 (translation elongation
factor 1) were all present at more than 1000 transcripts
per cell. At the other extreme, 1-8-23, 1-8-29, and I-8-
30B were present at 50 or fewer transcripts per cell at
the 8 h serum induction timepoint. The degree of reg-
ulation varied from a reproducible but modest 2-fold
induction of I-8-30B to more than 100-fold stimulation
of 1-8-1 (tenascin) and 50-fold repression of R-8-1 (al-
pha-1 [3] collagen). In asynchronous exponentially
growing cells, most species tested were expressed at
levels well below their peak in serum stimulated G, (for
the 1-8 series) or Go (for the R-8 series). The exception
was 1-8-41 (heat stable antigen, HSA) (Kay et al., 1990),
which was more highly expressed in cycling cells than
at any point tested during emergence from Go.
Regulatory Capacity of Conditional myc Expression
To screen the mid-SR clones for myc responsiveness,
we used an NIH 3T3 cell line (3-5B) that expresses c-
myc driven by the metallothionein-I promoter (Tavti-
gian, 1992). This cell line is subject to growth arrest in
defined medium, as is the parental NIH 3T3 line. As in
other conceptually similar cell lines with inducible myc
activity (Cavalieri and Goldfarb, 1987), ectopic c-myc
expression under arrest conditions is sufficient to stim-
ulate a subpopulation of the growth arrested cells (50-
60%) to reenter the cell cycle, traverse Gl, and enter S-
phase (Figure 3). During the course of such an experi-
ment, c-myc protein peaks at levels exceeding those
present in serum stimulated NIH 3T3 cells by 5- to 10-
fold (Figure 4). A second cell line used to verify myc
responsiveness was MER #6, a Balb/c 3T3 based cell
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Figure 2. Expression of cloned transcripts regulated in NIH 3T3 cells with mid-SR kinetics. NIH 3T3 cells were seeded and brought to growth
arrest in defined medium as indicated in MATERIALS,AND METHODS. Arrested cells were mock or serum stimulated. RNAs generated from
mock, serum stimulated, and exponentially growing cells were analyzed by ribonuclease protection. Quantitative data from each set of ribonuclease
protections were obtained from the dried gels on a phosphoimager (Molecular Dynamics). Using internal standards on each gel, transcripts per
cell was calculated as:
protected cpm (gg total RNA-') X 1 Ag total RNA X 6.02 X 1023 molecules mole-'
protected probe activity, cpm mol-1 50,000 cells
corrected for probe decay over the course of the experiment.
More accurately, this is a measure of transcripts per 20 pg of total RNA; in our experience, a reasonable estimate of the RNA content of a growth
arrested 3T3 cell.
(A) Reference serum response transcripts. (B) Serum induced transcripts. (C) Serum repressed transcripts. Timecourse: 0, mock induced; 1,
4, 8, 12, serum treated for 1, 4, 8, or 12 h; Gr, exponentially growing cells. Abbreviations: a-l(III)C, c-i type III collagen; EF-1, translation
elongation factor 1; a-l(VI)C, a-1 type VI collagen; MGSA, melanoma growth stimulatory activity; Tlp, Ti protein; LDH, lactate dehydrogenase;
LTT, liver thiol transferase; G3PDH, glyceraldehyde-3-phosphate dehydrogenase; ODC, omithine decarboxylase; HSA, heat stable antigen.
* Indicates that a particular measurement was not made.
line expressing a c-myc/estrogen receptor fusion protein
(Eilers et al., 1989, 1991). Fifty to sixty percent of MER
#6 cells reenter the cell cycle following hormonal ac-
tivation of the fusion protein (Eilers et al., 1991; see also
Figure 3).
To calibrate RNA responses by the selected mid-SR
genes to conditional c-myc we used several already
known Gl-regulated transcripts (the immediate early
genes c-fos and endogenous c-myc, and the mid-SR
gene p53 tumor antigen; tubulin ,B5 serves as an unaf-
fected control) (Figure 5). In both parental 3T3 cells and
myc23c expressing 3-5B cells, c-fos RNA was present
at very low levels and did not vary significantly with c-
myc expression. As shown previously (Eilers et al.,
1991), the immediate early burst of c-fos RNA synthesis
following serum stimulation is bypassed in a c-myc
stimulated emergence from Go. Endogenous c-myc RNA
levels were chronically repressed in 3-5B cells relative
to 3T3 cells; this was probably a consequence of basal
c-myc transgene expression in 3-5B cells. In addition,
the endogenous c-myc transcript was further repressed
over the timecourse of the myc transgene induction.
That myc itself shows different regulation in response
to full serum stimulation (up-regulation at mid-G, rel-
ative to Go) compared with the response to ectopic
transgene myc (down-regulation relative to Go), raises
the possibility that other genes from the mid-SR panel
might display disparate responses to the mitogen- versus
myc-driven Go-*.S experimental regimes.
p53 Transcript levels remained steady in control 3T3
cells treated with zinc, but they were induced 2- to 3-
fold between 4 and 12 h after zinc addition to 3-5B
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Figure 3. Emergence from growth arrest stimu
myc expression. (A) NIH 3T3 and conditional m
5B cells were seeded and brought to growth arres
as indicated in MATERIALS AND METHODS.
mock or zinc stimulated; zinc doses are indicates
toms. (B) Similar experiments comparing paren
with the c-myc estrogen receptor fusion protein
cell line MER #6. Cells were seeded and brough
medium containing 5% calf serum as indicated ir
METHODS. Arrested cells were mock or ,B-estra
ulated as indicated at bottom of each column. Cel
BrdU from 14 to 24 h following stimulation. Fix
peroxidase staining were as in MATERIALS AN
proximately 400 cells were counted for each zinc
is the number of peroxidase stained cells divided
of cells.
duction system to control for possible phenotypic effects
secondary to metal treatment. Unfortunately, regulation
z Bab/¢ of the myc23c transgene by glucocorticoids proved weak
and inconsistent in this cellular environment and was0MER m not pursued further. Instead, we substituted the cell
line MER #6, which expresses a c-myc/estrogen recep-
tor fusion protein (myc-ER) in the Balb/c 3T3 cell back-
ground (Eilers et al., 1989, 1991) (a kind gift from Sabine
Schirm and J. Michael Bishop).
Table 1 and Figure 6 present the effect of conditional
myc expression on the mid-SR regulated cDNAs. To
more simply visualize myc response in the two condi-
tional myc systems, Figure 6 presents data from Table
1 in a scatter diagram format. While most of the tran-
scripts cluster around (1,1), indicative of no significant
+ + response to elevated myc expression, I-8-1OB (lactate
O-estradiol dehydrogenase), 1-8-36 (ornithine decarboxylase), I-8-
29 (not found in the databases), and I-8-30B (not found
iyc23c expressing 3a in the databases) all lie in the upper right quadrant,
;t in defined medium indicative of induction by myc in both regimes. To better
Arrested cells were visualize myc-driven repression, the data were replotted
d at the column bot- in Figure 6B as the reciprocal of the values in 6A. In
ital Balb/c 3T3 cells this analysis, I-8-1 (tenascin) and 1-8-41 (heat stable
(t to growth arrest in antigen) lie in the upper right quadrant, indicative of
n MATERIALS AND repression by myc. Of the 18 mid-SR regulated mRNAs,
idiol (100 nM) stim-
Ils were labeled with
Kation and immuno-
JD METHODS. Ap-
dose; labeling index
by the total number
A ,S
-
I
l,
r- +i
69 kD-
cells, consistent with its timecourse of up-regulation in
response to serum stimulation (Reich and Levine, 1984).
This identifies p53 as a target, direct or indirect, of myc
in this system. This result is consistent with previous
observations that p53 is among the proteins that are
overexpressed in cells whose growth characteristics have
been altered by chronic c-myc overexpression (Shiroki
et al., 1986), although it has been difficult in such sys-
tems to discriminate obligate responses to myc from
long term indirect effects. As discussed later, other in-
dependent molecular data argue that p53 is a good can-
didate for direct regulation by myc. Its response is con-
sistent with that possibility but also suggests that the
magnitude of myc response expected from unknown
genes in the mid-SR panel may be quantitatively mod-
est, as is the case for p53.
Identification of myc Regulated Transcripts Among
Mid-SR Regulated Clones
The metallothionein promoted c-myc gene expressed
by 3-5B cells included an upstream glucocorticoid reg-
ulated enhancer derived from MMTV. We had originally
planned to use this second, metal-independent myc in-
46 kD-
1 2 3 4
B 3-5B cells
Time at harvest (hours)
0 .5 1 2 4 8 16
69 kD-
Figure 4. Western analysis of c-myc protein expression in NIH 3T3
and myc23c expressing 3-5B cells. (A) (-): cells were mock induced.
(+): 3T3 cells were induced by adjusting the medium to 5% fetal
bovine serum. 3-5B cells were induced by adjusting the medium to
20 uM ZnSO4. All cells were harvested after 4 h of induction. (B) 3-
5B cells were harvested over a 16 h timecourse following induction.
Cells in the "0" timepoint were harvested 4 h after mock induction.
The other samples were harvested at the times indicated at the tops
of the lanes. Cells were seeded, brought to growth arrest, induced,
harvested, and blotted as indicated in MATERIALS AND METHODS.
The labeling antibody was 125I conjugated anti c-myc monoclonal
H60C37.
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Figure 5. Comparison of selected mRNA expression in NIH 3T3
and myc23c expressing 3-5B cells. NIH 3T3 and 3-5B cells were seeded
and brought to growth arrest in defined medium as indicated in MA-
TERIALS AND METHODS. Arrested cells were either mock stimulated
or treated with 20 gM zinc. RNAs generated from mock and zinc
treated cells were analyzed by ribonuclease protection. Timecourse:
0, mock stimulated cells; .5--112, cells treated with zinc for 0.5 to 12
h. Please note that the ratio of the sensitivity of the c-myc to myc23c
protections was 8:1; the sensitivity of the c-fos protection was equiv-
alent to that of the c-myc protection, just sufficient to detect basal c-
fos expression.
5 (lactate dehydrogenase, ornithine decarboxylase, te-
nascin, 1-8-29, and I-8-30B) are induced or repressed
more than twofold following stimulation of myc
expression in one of the two systems; in each case, that
same mRNA is regulated in the same manner, though
not necessarily to the same degree, in the alternate myc
expressing cell system. Expression from the immediate
early serum response genes c-fos, c-jun, and c-myc and
the previously identified myc-responsive gene prothy-
mosin a were also measured in this experiment. Myc
behaved essentially as before in 3-5B cells (Figure 5),
while in MER #6 cells myc was constitutively repressed
to very low levels, presumably due to basal activity from
the myc-ER fusion protein (Eilers et al., 1989). Neither
c-fos nor c-jun responded to myc expression in either
system. Prothymosin a was induced in 3-5B cells, con-
firming in this NIH 3T3 cellular background the original
observation of myc inducibility reported in MycER ex-
pressing Rat 1 cells (Eilers et al., 1991).
The RNA level comparisons between the NIH 3T3
and Balb/c 3T3 based conditional myc systems were
made in the experimental condition of growth arrest at
low density in serum free defined medium. Primary
RNA level data for the key myc responses observed in
that growth arrest condition are shown in Figure 7A.
In addition, Balb/c 3T3 and MER #6 cells can also be
brought to growth arrest efficiently by contact inhibition
in medium containing 5% calf serum (Figure 3). The
entire set of genes up-regulated by conditional myc in
MER #6 cells arrested in defined medium also re-
sponded to conditional myc in this second arrest par-
adigm. Furthermore, most of those transcripts, especially
prothymosin a, responded more strongly to conditional
myc in this system than in the defined medium growth
arrest system (Figure 7B).
Myc Stimulates Target Genes at the
Transcriptional Level
Responses to conditional myc could be either transcrip-
tional or post-transcriptional. If a target gene is regulated
by a transcriptional mechanism, it then becomes a can-
didate for direct regulation by myc-containing tran-
scription factors. Nuclear run-on assays were done to
test for transcription level regulation of myc targets. Due
to the limited sensitivity of nuclear run-ons, we focused
on the most robustly induced myc target genes: 1-8-1OB
(lactate dehydrogenase), 1-8-29 (not found in data base)
and 1-8-36 (ornithine decarboxylase). Figure 8 presents
the results from a representative run-on experiment in
which MER #6 cells were brought to density arrest and
then treated with estrogen to induce the myc-ER protein
activity. After 3 h of stimulation, we consistently ob-
served an increase of the myc regulated run-off tran-
scripts. Quantitation was done using a phosphoimager
and revealed that after 3 h of stimulation, I-8-29 in-
creased by fivefold over the zero time point. Since I-8-
lOB (lactate dehydrogenase) and I-8-36 (ornithine de-
carboxylase) were below the threshold of detection in
unstimulated cells, we could not calculate a fold-in-
duction. However, by placing a generous maximum
limit on the largest signal that would have gone un-
detected at the zero time point, we can estimate that
stimulation was greater than or equal to 12- and 8-fold
at 3 h for I-8-1OB (lactate dehydrogenase) and I-8-36
(ornithine decarboxylase), respectively. Conversely, af-
ter 3 h of estrogen stimulation, myc run-off transcripts
decreased by 80%, which also shows that the zero time
transcription was not simply defficient in transcription
from all genes. These results show that the mechanism
of myc induction for 1-8-29, ODC, and LDH is, at least
in part, transcriptional. The observed transcriptional ef-
fects do not preclude additional, secondary post-tran-
scriptional effects such as mRNA stabilization, but at
these early kinetic points, transcription appears to ac-
count for the observed increase in RNA levels.
DISCUSSION
Differences and Similarities Between Serum-driven
and myc-driven Emergence From Go
Following stimulation of ectopic myc expression in Go
arrested cells, both 3-5B and MER #6 cells emerge from
growth arrest, progress through Gl, and enter S-phase.
However, in these systems only a fraction (usually 40-
50%) of the arrested cells ultimately enter S-phase (Fig-
ure 3). In contrast, >95% of these same cells will enter
S-phase following serum stimulation, which suggests
that there is at least a significant quantitative difference
in the responsiveness of cells to myc versus serum; in
principle, a substantial qualitative difference might also
exist although there has been no direct evidence for
this. Our results provide direct evidence for qualitative
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Table 1A. cDNA clones subject to serum regulation with mid-SR kinetics
Cell system
NIH3T3 3-5B MER #6
Induction (8 h)
Clone Clone identity By serum' By conditional mycb expression
I-8-1 Tenascin 110 0.69 0.33 ± 0.2
I-8-6 MGSAC 8.6 1.0 0.66 ± 0.1
I-8-9 Not identified 3.6 1.0 0.84 ± 0.3
I-8-10A Mouse Ti protein 26 0.9 Not detected
1-8-1OB Lactate dehydrogenase 8.9 2.21 2.0 ± 0.1
I-8-16 A-X actin 4.6 0.6 0.88 ± 0.1
I-8-23 Not identified 3.2 Not done 0.96 ± 0.3
I-8-29 Not identifiedd 5.1 1.73 5.0 ± 0.6
I-8-30B Not identified 2.0 2.6 1.4 ± 0.2
1-8-32 Liver thiol transferase 7.0 1.1 0.86 ± 0.1
1-8-33 G-3-P dehydrogenasee 2.9 1.2 1.0 ± 0.1
1-8-34 Not identified 28 0.89 1.3 ± 0.7
I-8-36 Ornithine decarboxylase 2.6 3.96 1.7 ± 0.2
I-8-41 Heat-stable antigen 4.6 Not detected 0.5 ± 0.1
I-8-47 Not identified 70 1.49 1.4 ± 0.2
Repressionf
By serum
at 12 h By conditional myc expression at 8 h
R-8-1 Alpha-i (3) collagen 50 1.7 1.0 ± 0.1
R-8-9 Elongation factor 1 2.4 Not done 1.1 ± 0.2
R-8-26 Alpha-i (6) collagen 2.7 Not done 1.1 ± 0.1
a Induction by serum: transcript prevalence in serum stimulated cells divided by transcript prevalence in growth arrested cells.
b Induction by conditional myc expression:
fold change upon induction in conditional cell line
fold change upon induction in control 3T3 cell line
c MGSA: melanoma growth stimulatory activity.
d Shares some sequence homology with methylenetetrahydrofolate synthetase.
eG-3-P dehydrogenase: glyceraldehyde-3-phosphate dehydrogenase.
f Repression values are the reciprocal of induction values.
Accession numbers: I-8-1 (D90343); I-8-6 (X12510); 1-8-9 (U06663); I-8-10A (M24843); 1-8-1OB (M27554); I-8-16 004181); 1-8-23 (U06664);
I-8-29 (U06665); I-8-30B (U06666); 1-8-32 (M31453); I-8-33 (M32599); I-8-34 (U06667); 1-8-36 (M10624); I-8-41 (M58661); I-8-47 (U06668);
R-8-01 (X06700); R-8-26 004598).
differences as well as quantitative ones, and suggest
that myc driven progression is not merely a subset of
the events that occur in response to serum. Divergence
between serum- and myc-driven GI phases was re-
vealed in the cases of endogenous myc and tenascin (I-
8-1), an extracellular matrix protein (for review, see Sage
and Bomstein, 1991). Both were upregulated by serum
but downregulated by conditional myc expression. The
differential response of tenascin to myc versus serum
may have functional implications for the limited on-
cogenic effects of deregulated myc, by itself, in fibroblast
and mesenchymal cell types, as tenascin upregulation
has been associated with tumor progression (Inaguma
et al., 1988). Thus efficient growth transformation of
such cells normally requires collaboration of myc with
activated Ras or additional growth factors (Bishop,
1986). It will therefore be interesting to test whether
ectopic tenascin expression results in progression of
myc immortalized cells to a more aggressively trans-
formed, tumorgenic state without additional input from
activated Ras.
Comparison of the serum response with myc response
also showed that many genes regulated by serum do
not respond detectably to myc. In some cases, these
differences are striking in their magnitude [Ti protein
(I-8-10A) and 1-8-34]. Recently gained knowledge about
the components of the immediate early regulatory class
provides a possible explanation. Some prominent
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Table 1B. cDNA clones subject to serum regulation
with mid-SR kinetics
Induction (8 h)
By By conditional
seruma mycb expression
Cell system
NIH 3T3 3-5B MER #6
Alpha prothymosin 1.7 3.3 1.2 ± 0.1
c-Myc 15 0.36 0.76 ± 0.4
Max/myn 2.4 2.1 1.2 ± 0.3
p53 Tumor antigen 3.8 2.3 1.2 ± 0.2
c-fos 0.83 0.96 Not done
c-jun 0.80 0.79 Not done
fra-1 8.5 1.0 Not done
HSP 70 MHS 214 3.0 1.2 Not done
Id 31 0.89 Not done
a Induction by serum: transcript prevalence in serum stimulated cells
divided by transcript prevalence in growth arrested cells.
b Induction by conditional myc expression:
fold change upon induction in conditional cell line
fold change upon induction in control 3T3 cell line
members of the immediate early serum response are
not at all induced by ectopic myc; rather, in a myc driven
emergence from Go regulators such as c-fos and c-jun
are apparently bypassed (Eilers et al., 1991; Yang et al.,
1991; see also Figure 5 and Table 1). It therefore seems
likely that some mid-SR class genes would depend
heavily or entirely on the bypassed regulators, and little
or not at all on c-myc. Even the limited panel of mid-
SR genes presented here includes a dozen that are good
candidates for regulation by non-myc immediate early
regulators.
At the cellular level, a straightforward conclusion is
that myc-insensitive mid-SR products are not essential
for progression to S-phase, although they may very well
account for differences in the character and quantitative
success of the full mitogen response compared with the
myc response. However, viewed from a different per-
spective, a second and nonexclusive possibility is that
some mid-SR genes found to be absent from the myc
response class actually contribute to myc induced cell
cycle progression by their absence. These might include
regulators that are important because they normally
function as checks to limit progression toward S-phase
in a full serum response. Finally, the observed differ-
ences between the myc-responsive set and the larger
serum responsive group point to another possibility that
our experiments did not address; there may be genes
that are regulated by myc in the absence of serum that
are not regulated at all by serum. In the two step screen
used here, these would have been absent from the
starting pool. A direct plus/minus myc subtractive
screen will be needed to find them.
Genes that responded similarly to myc and to serum
were lactate dehydrogenase (I-8-1OB), I-8-29, omithine
decarboxylase (I-8-36), and p53 tumor antigen. These
similarly affected products are candidates for proteins
obligatorily involved in the regulation or execution of
any successful progression from Go to S-phase. This
expectation is supported by the recent reports that forced
expression of ODC in 3T3 cells is tumorgenic (Auvinen
et al., 1992; Moshier et al., 1993).
Transcriptional Responses to Conditional myc
Nuclear run-on experiments showed that several myc-
induced genes are responding transcriptionally. In this
connection, it is interesting that the promoter regions
of lactate dehydrogenase, omithine decarboxylase, and
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Figure 6. Scatter diagram analysis of mid-SR regulated transcript
expression in conditional myc expressing 3-5B and MER #6 cells.
Data are from Table 1. (A) Data for each transcript are plotted on a
scatter diagram. The X-value for each point is
fold change upon induction in MER #6 cells
fold change upon induction in Balb/c 3T3 cells'
The Y-value for each point is
fold change upon induction in 3-5B cells
fold change upon induction in NIH 3T3 cells
The Balb/c MER #6 experiment was iterated 3 times; the plotted data
are average values and the X-error bars delimit ± SD for these data.
Clone numbers are provided for those transcripts that were clearly
upregulated by conditional myc expression. (B) Data for each transcript
are replotted on a scatter diagram where the X- and Y-values are the
reciprocals of the values in part A. Clone numbers are provided for
those transcripts that were clearly downregulated by conditional myc
expression. Where a myc-independent transcript was either not mea-
sured or not detected in 1 of the 2 cell systems (see Table 1), its data
point is placed on 1 of the axes using the fold-regulation value mea-
sured in 1 system only. The transcript 1-8-41 (heat stable antigen) is
not expressed in the specific NIH 3T3 isolate used to construct 3-5B
cells. However, the transcript is reproducibly repressed by conditional
myc expression in the Balb/c MER #6 system. Therefore, its data
point is arbitrarily placed on the main diagonal at the value determined
in the Balb/c MER #6 system.
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Figure 7. Expression of selected myc regulated transcripts. (A) NIH
3T3, myc23c expressing 3-5B, Balb/c 3T3, and mycER expressing
MER #6 cells were seeded and brought to growth arrest in defined
medium as indicated in MATERIALS AND METHODS. NIH 3T3 and
3-5B cells were mock or zinc treated; Balb/c and MER #6 cells were
f,-estradiol treated. (B) Balb/c 3T3 and MER #6 cells were seeded and
brought to growth arrest by contact inhibition in medium containing
5% calf serum as indicated in MATERIALS AND METHODS. In both
experimental regimes, cells were harvested after 8 h of stimulation.
RNAs were analyzed by ribonuclease protection. The induced zinc
condition was 20 ,M for all transcripts except for 1-8-29, for which
it was 15 gM. The induced (3-estradiol condition was 100 nM in all
cases. Abbreviations: LDH, lactate dehydrogenase; ODC, omithine
decarboxylase.
p53 tumor antigen all contain potential myc binding
sites as previously defined by in vitro target site selection
experiments (Blackwell et al., 1990; Halazonitas and
Kandil, 1991; Kerkhoff et al., 1991). We have recently
shown that the myc-type E-box within the LDH pro-
moter is a good in vitro binding site for myc:Max/myn
heteromers or Max/myn:Max/myn homo-oligomers
(Tavtigian, 1992). Also, a potential myc binding site
within the mouse p53 promoter, located just down-
stream of the cap site, is a positive regulator of p53
expression (Ronen et al., 1991; Reisman et al., 1993).
Furthermore, recent work has also demonstrated that
c-myc transactivates ODC promoter-reporter con-
structs through an E-box inintron I of the ODC gene
(Bello-Fernandez et al., 1993). These genes may
therefore be directly regulated by a c-myc:Max/myn
heteromer in its role as a transcription factor or by
Max/myn homo-oligomers, although other tran-
scription factors, notably USF/MLTF and TFII-i (Car-
thew et al., 1985; Gregor et al., 1990; Roy et al., 1991),
can recognize the same core sequence and their in-
volvement has not been ruled out. It will now be cru-
cial to understand in detail the balance between levels
of myc and Max/myn hetero- and homo-oligomers
and how these levels correlate with the responses to
myc and serum reported here. A relevant observation
from this work was that induction of ectopic myc in
3-5B cells results in up-regulation of Max/myn RNA,
so that active myc:Max/myn heteromers are probably
able to form.
Other myc Target Genes
Several prior studies have been directed at identification
of myc regulatory targets, and some of these targets
were screened in the course of this work for respon-
siveness in the Go - S-phase inducible system. Chronic
overexpression of myc leads to transcriptional repression
of c-myc and to repression of MHC class I transcripts
(Bemards et al., 1986; Cleveland et al., 1988; Versteeg
et al., 1988; Grignani et al., 1990; Penn et al., 1990). We
found here that myc autorepression is also observed
upon short-term myc overexpression. In constitutive
myc overexpressing lines, Prendergast and Cole were
able to identify two myc regulated clones, MR1 (plas-
minogen activator inhibitor 1), and MR2. At the mech-
anistic level, their data suggested that regulation was
post-transcriptional in both cases (Prendergast et al.,
1990). Yang et al., (1991) identified three collagen tran-
scripts transcriptionally repressed by c-myc over-
expression, and Eilers et al., (1991) found that prothy-
mosin a is transcriptionally induced by a c-myc/
estrogen receptor fusion protein in a Rat-i cell back-
ground, though not in a Balb/c 3T3 cell background
(Eilers et al., 1991; Yang et al., 1991, Hevezi and Bishop,
personal communication). Here we found prothymosin
a to be myc-responsive in a manner that varied ac-
cording to cell background and growth arrest paradigm.
We therefore believe it belongs in the group that are
not essential for progression but are nevertheless myc
responsive in some cellular environments. Recently,
several cyclins have been tested for their responses to
myc (ansen-Durr et al., 1993; Tavtigian, Zabludoff, and
Wold, unpublished observations). These are particularly
interesting because a large body of evidence identifies
the cyclins as pivotal elements in regulating cell cycle
progression (Richardson et al., 1992; Pines, 1993; Sherr,
Estrogen timecourse
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Figure 8. Nuclear run-on assay of myc regulated transcripts. MER
#6 cells were seeded and brought to growth arrest by contact inhibition
in medium containing 5% calf serum as indicated in MATERIALS
AND METHODS. Cells were treated for 1 and 3 h with 100 nm ,8-
estradiol and nuclei harvested as described in MATERIALS AND
METHODS. Run-off transcripts were generated from freshly isolated
nuclei, and approximately equal counts were added to each hybrid-
ization. Abbreviations: LDH, lactate dehydrogenase; ODC, ornithine
decarboxylase.
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1993). In both studies, cyclin-E RNA levels were prom-
inently upregulated by conditional c-myc activity, and
we found that the regulation is transcriptional. Because
ectopic cyclin E expression is sufficient to drive cell cycle
progression in human fibroblasts (Ohtsubo and Roberts,
1993), this raises the possibility that cyclin E is a direct
myc target that is sufficient to drive the Go to S transition,
although it does not rule out significant contributions
to execution from other genes.
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